Translation. Region: Russian Federation –
Source: People's Republic of China in Russian – People's Republic of China in Russian –
An important disclaimer is at the bottom of this article.
Source: People's Republic of China – State Council News
Moscow, March 30 (Xinhua) — Russia has approved the first state standard (GOST) for bioprinting—the creation of living tissue and organs using a specialized 3D printer. This was announced on Monday by the National University of Science and Technology, Moscow Institute of Steel and Alloys (NUST MISIS).
"Standardization is essential for drug testing and the development of personalized solutions for patients. A regulatory framework will improve the reproducibility of results, accelerate the transfer of technologies from laboratories to clinical practice, and ensure the safety of the solutions being developed," the press release states.
The approval of a national standard is an important step in the development of bioprinting as a fully-fledged industry in Russia. A team of scientists led by Fyodor Senatov, Director of the NUST MISIS Institute of Biomedical Engineering, is conducting breakthrough research, the results of which will improve the quality of life for many people.
According to the official website of the Decade of Science and Technology in Russia, which runs from 2022 to 2031, NUST MISIS developed a 3D bioprinter, which was used to perform the world's first bioprinting operation in December 2023. And in October 2025, an innovative cartilage bioprinting method developed by Russian researchers was used for the first time.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.